Co-Authors
This is a "connection" page, showing publications co-authored by Bruno Lina and Yazdan Yazdanpanah.
Connection Strength
0.562
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.218
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort. J Infect. 2021 05; 82(5):186-230.
Score: 0.058
-
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France. Euro Surveill. 2021 01; 26(1).
Score: 0.058
-
COVID-19: France grapples with the pragmatics of isolation. Lancet Public Health. 2020 11; 5(11):e573-e574.
Score: 0.057
-
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia. Cell Rep Med. 2020 07 21; 1(4):100059.
Score: 0.056
-
France's COVID-19 response: balancing conflicting public health traditions. Lancet. 2020 07 25; 396(10246):219-221.
Score: 0.056